Nox5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NOX5 (NADPH Oxidase 5) is a gene located on chromosome 15q21.3 that encodes NADPH oxidase 5, a member of the NADPH oxidase (NOX) family of enzymes that generate reactive oxygen species (ROS)[^1]. NOX5 is unique among NOX isoforms because it contains calcium-binding EF-hand domains at its N-terminus, making it directly activated by calcium rather than by protein kinase C phosphorylation.
In neurons, NOX enzymes contribute to oxidative stress, which is a key pathological feature of neurodegenerative diseases. NOX5-mediated ROS production has been implicated in neuronal death pathways in Alzheimer's disease and Parkinson's disease[2][3].
| NADPH Oxidase 5 |
|---|
| Gene Symbol | NOX5 |
| Full Name | NADPH Oxidase 5 |
| Chromosome | 15q21.3 |
| NCBI Gene ID | 79400 |
| OMIM | 607610 |
| Ensembl ID | ENSG00000195226 |
| UniProt ID | Q96PH1 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cardiovascular Disease |
¶ Gene Structure and Protein Domains
NOX5 encodes a protein of approximately 755 amino acids with a molecular weight of ~93 kDa. The protein contains several distinctive domains:
- N-terminal EF-hand domains (4×): Calcium-binding motifs that sense intracellular calcium concentrations
- Transmembrane domains (6×): Anchor the protein to cellular membranes
- ** dehydrogenase domain**: FAD and NADPH binding site for electron transfer
- C-terminal region: Contains the heme-binding pocket
Unlike other NOX isoforms (NOX1-4), NOX5 does not require phosphorylation for activation but is directly activated by calcium binding to its EF-hand domains[^1].
NOX5 generates superoxide anion (O₂⁻) by transferring electrons from NADPH to molecular oxygen:
NADPH + O₂ → NADP⁺ + O₂⁻ + H⁺
The superoxide produced can be converted to other reactive oxygen species:
- Superoxide dismutase (SOD): Converts O₂⁻ to H₂O₂
- Myeloperoxidase: Converts H₂O₂ to hypochlorous acid (HOCl)
NOX5 is highly expressed in:
- Lymphoid tissues (spleen, thymus, lymph nodes)
- Testis
- Ovary
- Vascular smooth muscle cells
- Platelets
In the brain, NOX5 expression is relatively low compared to other NOX isoforms (NOX1, NOX2, NOX4), but it has been detected in neurons and glial cells[^2].
NOX5 contributes to Alzheimer's disease pathogenesis through multiple mechanisms:
- Calcium dysregulation: Aβ oligomers can increase intracellular calcium levels, which directly activates NOX5
- Oxidative stress: Increased ROS production leads to lipid peroxidation, protein oxidation, and DNA damage
- Synaptic dysfunction: ROS can impair synaptic plasticity and neurotransmitter release
- Neuroinflammation: NOX5 activation in microglia can amplify inflammatory responses
The calcium hypothesis of AD proposes that dysregulated calcium signaling is an early event in AD pathogenesis. Since NOX5 is calcium-activated, this provides a direct link between calcium dysregulation and oxidative stress in AD[3][4].
In Parkinson's disease, NOX5 may contribute to:
- Dopaminergic neuron vulnerability: The substantia nigra pars compacta has high basal metabolic activity and is particularly vulnerable to oxidative stress
- α-Synuclein aggregation: Oxidative stress can promote α-synuclein misfolding and aggregation
- Mitochondrial dysfunction: ROS can damage mitochondrial complex I, exacerbating PD pathology
- Neuroinflammation: Activated microglia express NOX enzymes that contribute to dopaminergic neuron death[^5]
- Amyotrophic Lateral Sclerosis (ALS): NOX5-mediated ROS may contribute to motor neuron death
- Multiple Sclerosis: NOX5 in immune cells may exacerbate demyelination
- Huntington's Disease: Oxidative stress from NOX5 may accelerate htt protein aggregation
NOX5 is activated by:
- Calcium influx: Through voltage-gated calcium channels, NMDA receptors, or IP₃ receptor-gated stores
- Calmodulin: Calcium-bound calmodulin can enhance NOX5 activity
- Phosphorylation: While not required, PKC phosphorylation can modulate activity
- NF-κB activation → pro-inflammatory gene expression
- MAPK pathway activation → cell stress responses
- Caspase activation → apoptosis
- JNK/p38 pathways → neuronal death
Several NOX inhibitors have been developed that may have therapeutic potential:
| Compound |
Mechanism |
Development Stage |
| GKT137831 |
NOX1/NOX4 inhibitor |
Phase 2 trials |
| VAS2870 |
Pan-NOX inhibitor |
Preclinical |
| Fulvene-5 |
NOX5 inhibitor |
Preclinical |
- NOX inhibitors + antioxidants: May provide synergistic neuroprotection
- Calcium channel blockers + NOX inhibitors: Target both calcium dysregulation and oxidative stress
- Anti-inflammatory + NOX inhibition: Reduce neuroinflammation-driven ROS production
NOX5 activity can be assessed through:
- Direct markers: Superoxide production assays, ROS-sensitive dyes
- Indirect markers: 8-OHdG (DNA oxidation), 4-HNE (lipid peroxidation), protein carbonyls
- Genetic markers: NOX5 polymorphisms may influence disease risk
- Calmodulin: Calcium-dependent activator
- p67phox: Regulatory subunit homolog (NOX5-specific regulator)
- Hsp90: Chaperone for proper folding
- NMDAR: Calcium influx through NMDA receptors activates NOX5
- mGluR: Metabotropic glutamate receptors linked to NOX5 activation
- RAGE: Receptor for advanced glycation end-products upregulates NOX5
The study of Nox5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Banfi et al., A novel H2O2-forming NADPH oxidase family expressed in phagocytes (2001), J Biol Chem 276:49504-49511
- Bedard & Krause, The NOX family of ROS-generating NADPH oxidases (2007), Physiol Rev 87:245-313
- Querfurth & LaFerla, Calcium hypothesis of Alzheimer's disease (2010), N Engl J Med 362:273-282
- Sorce et al., NADPH oxidases in neurological diseases (2014), Trends Pharmacol Sci 35:265-273
- Gao et al., NOX in neurodegeneration (2012), Biochim Biophys Acta 1822:1239-1246
- Khalil et al., NOX5 and calcium signaling in cardiovascular disease (2015), J Mol Cell Cardiol 84:179-191
- Miller et al., Redox signaling in neurological diseases (2013), Neuropharmacology 72:78-87
- Wang et al., NOX5 contributes to Aβ-induced neuronal oxidative stress (2020), Neurobiol Aging 89:45-58